Chemists have synthesized anti-Bredt olefins, a class of molecules previously deemed too unstable to exist, opening new avenues for drug development.
The synthesis of anti-Bredt olefins challenges a century-old belief that their double bond configuration at the bridgehead position was impossible, underscoring the importance of thinking outside existing scientific rules.
Neil Garg, a co-author of the study, emphasizes the significance of this breakthrough, stating, "We can be thinking a little bit more outside of the box," which reflects a shift in chemists' approach to molecular design.
Previously thought to be unstable due to their 3D construction, the newly synthesized anti-Bredt olefins demonstrate potential for advancing pharmaceutical research.
Collection
[
|
...
]